| 1 |
31097363 | Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs. | 2019 Sep - Oct |
1 |
| 2 |
20821051 | Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up. | 2010 Dec |
1 |
| 3 |
19898953 | Miglustat therapy in juvenile Sandhoff disease. | 2009 Dec |
1 |
| 4 |
18588514 | Identification and characterization of mature beta-hexosaminidases associated with human placenta lysosomal membrane. | 2008 Aug |
1 |
| 5 |
17994285 | Increased lung surfactant phosphatidylcholine in patients affected by lysosomal storage diseases. | 2007 Nov |
1 |
| 6 |
12662933 | Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. | 2003 Apr 11 |
1 |
| 7 |
12760286 | Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant. | 2003 May |
2 |
| 8 |
11278374 | Degradation of membrane-bound ganglioside GM2 by beta -hexosaminidase A. Stimulation by GM2 activator protein and lysosomal lipids. | 2001 Apr 20 |
1 |
| 9 |
9572057 | Biology and potential strategies for the treatment of GM2 gangliosidoses. | 1998 Apr |
1 |
| 10 |
7766021 | Purification of a chitooligosaccharidolytic beta-N-acetylglucosaminidase from Bombyx mori larvae during metamorphosis and the nucleotide sequence of its cDNA. | 1995 Feb |
1 |
| 11 |
3935131 | Molecular forms of GM2-activator protein. A study on its biosynthesis in human skin fibroblasts. | 1985 Sep |
1 |
| 12 |
6225718 | Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species. | 1983 Jul |
1 |
| 13 |
7451432 | Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain. | 1981 Jan 10 |
1 |